Aspire Biopharma Holdings, Inc.
ASBP
$8.87
-$0.38-4.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.27M | -3.22M | -4.71M | -1.85M | -1.98M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 1.58M | 6.00M | 2.02M | -- |
| Total Other Non-Cash Items | -1.17M | 8.80K | -3.10M | -1.59M | 1.18M |
| Change in Net Operating Assets | 319.40K | -1.41M | 881.70K | 318.40K | -340.40K |
| Cash from Operations | -2.12M | -3.04M | -927.80K | -1.10M | -1.14M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 2.00M | 0.00 | 7.25M | 0.00 |
| Total Debt Repaid | -499.20K | -3.06M | -16.50K | -3.50M | 0.00 |
| Issuance of Common Stock | -- | -- | 545.50K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | -- |
| Issuance of Preferred Stock | 9.00M | 8.95M | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -75.00K | -- | -545.50K | -907.50K | 0.00 |
| Cash from Financing | 8.43M | 7.89M | -16.50K | 2.85M | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 6.31M | 4.85M | -944.40K | 1.74M | -1.14M |